GLP-1 AND DUAL AGONISTS In summary, the research progress of GLP-1 in lipid metabolism shows its potential in the treatment of metabolic disorders such as NAFLD, especially combined with its significant weight loss effect, making the application of GLP-1 in obese patients with NAFLD more worthy of in-depth exploration
In cells that survive treatment, 5FU promotes a sustained increase in mitochondrial content over 72 h, as shown by changes in levels of nonyl-acridine orange (NAO) staining (Fig
Route selection Subcutaneous (SC): Standard route for musculoskeletal injuries
10.1523/JNEUROSCI.0415-09.2009 [DOI] [PMC free article] [PubMed] [Google Scholar] Xu W., Chen C., Li J
doi: 10.4061/2011/391762 116 VitariACDeakMCollinsBJMorriceNPrescottARPhelanAet al
It is responsible for the breakdown of complex and undigested polysaccharides, particularly mucin, resistant starch, and oligosaccharides, which the human body cannot metabolize on its own (151, 152)